<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="29767">Nitroxides</z:chebi> are <z:chebi fb="11" ids="22586">antioxidants</z:chebi> that are known to protect cells from oxidative damage </plain></SENT>
<SENT sid="1" pm="."><plain>Polynitroxyl albumin (<z:chebi fb="3" ids="48021">PNA</z:chebi>) is a compound of human serum albumin covalently labeled with <z:chebi fb="0" ids="29767">nitroxides</z:chebi> that exhibits a prolonged half-life and an enhanced <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity </plain></SENT>
<SENT sid="2" pm="."><plain>Adult male Sprague-Dawley rats were subjected to 90 min intraluminal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and the drug was administered intravenously immediately or 2 h after reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>The effects of the drug were evaluated 24 h after reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was significantly reduced in immediate (79% reduction) and delayed (53% reduction) <z:chebi fb="3" ids="48021">PNA</z:chebi>-treated groups </plain></SENT>
<SENT sid="5" pm="."><plain>The efficacy of a single, delayed i.v. injection of <z:chebi fb="3" ids="48021">PNA</z:chebi> suggests that <z:chebi fb="3" ids="48021">PNA</z:chebi> has great promise in the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> human <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>